Trade

with

Supernus Pharmaceuticals Inc
(NASDAQ: SUPN)
AdChoices
7.49
-0.35
-4.46%
After Hours :
7.49
+0.00
+0.01%

Open

7.97

Previous Close

7.84

Volume (Avg)

483.10k (421.75k)

Day's Range

7.45-8.13

52Wk Range

6.05-11.47

Market Cap.

321.48M

Dividend Rate ( Yield )

-

Beta

1.56

Shares Outstanding

42.92M

P/E Ratio (EPS)

-

AdChoices
Financials
  • Income Statement
  • Balance Sheet
  • Cash Flow
Operating Income
-61.92M
Operating Margin
-515.18
Total Equity
-
Retained Earnings
-
Free Cashflow
-
Price/Cashflow
-
Ownership

Institutional Ownership

-

Top 10 Institutions

101.62%

Mutual Fund Ownership

22.68%

Float

60.17%

5% / Insider Ownership

1.56%

Corporate insiders or major stockholders reporting trading activity in the stock.

Top Mutual Fund Owners

Top Institutional Owners

Mutual Fund Name

Institution Name

  • Mutual Fund Name

  • Shares Held

  • % Change

  • % Outstanding

  • T. Rowe Price Health Sciences Fund

  •  

    1,549,200

  • -27.72

  • 3.68

  • T. Rowe Price New Horizons Fund

  •  

    1,218,900

  • -2.10

  • 2.89

  • Columbia Small Cap Core Fund

  •  

    688,656

  • 0.00

  • 1.60

  • Worldwide Healthcare

  •  

    580,000

  • 0.00

  • 1.38

  • iShares Nasdaq Biotechnology

  •  

    557,905

  • -0.24

  • 1.17

  • Vanguard Total Stock Mkt Idx

  •  

    465,212

  • 0.00

  • 1.08

  • iShares Russell 2000 (AU)

  •  

    449,763

  • -1.81

  • 0.95

  • Bruce Fund

  •  

    400,000

  • 300.00

  • 0.93

  • Columbia Small Cap Value Fund I

  •  

    380,836

  • 0.00

  • 0.89

  • Mutual of America Small Cap Growth

  •  

    355,272

  • -19.57

  • 0.84

  • Institution Name

  • Shares Held

  • % Change

  • % Outstanding

  • NEA Management Company, LLC

  •  

    10,650,000

  • 0.00%

  • 25.04

  • Abingworth LLP

  •  

    3,600,000

  • 0.00%

  • 8.53

  • Abingworth Management Ltd

  •  

    3,277,869

  • -8.95%

  • 7.64

  • T. Rowe Price Associates, Inc.

  •  

    2,815,530

  • -6.20%

  • 6.56

  • Discovery Group I, Llc

  •  

    2,785,153

  • +21.01%

  • 6.49

  • Ardsley Advisory Partners

  •  

    1,765,000

  • +11.01%

  • 4.19

  • Columbia Mangmt Investment Advisers, LLC

  •  

    1,732,581

  • -6.72%

  • 4.11

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers – Specific & Generic

Type

Distressed

Style

-

Supernus Pharmaceuticals Inc., was incorporated in Delaware on March 30, 2005. It is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, includin...moreg neurological and psychiatric disorders. The Company markets two epilepsy products, Oxtellar XR and Trokendi XR, and has several proprietary product candidates in clinical development that address the attention deficit hyperactivity disorder market. The Company has a broad portfolio of drug development technologies consisting of six platforms that include the following: Microtrol, Solutrol (matrix delivery platform) and EnSoTrol. In addition to Oxtellar XR and Trokendi XR, the Company’s proprietary technologies have been used in the following approved products: Carbatro...morel, Adderall XR, and Intuniv, marketed by Shire; Equetro, marketed by Validus Pharmaceuticals Inc.; Sanctura XR, marketed by Allergan, Inc.; Oracea, marketed by Galderma Laboratories, L.P.; and Orenitram. Oxtellar XR and Trokendi XR are novel extended release formulations of two well known and approved AEDs, oxcarbazepine and topiramate. The Company’s psychiatry portfolio includes three product candidates for the treatment of impulsive aggression in patients with ADHD, ADHD or its coexisting conditions and one product candidate for depression, each of which is designed to bring important advancements in therapy. In addition to regulations in the United States, the Company will be subject to a variety of foreign regulations governing clinical trials and commercial sales and distribution of the product candidates to the extent company choose to clinically evaluate or sell any products outside of the United States.lessless

Key People

Jack Khattar

CEO/Director/President/Secretary

Dr. M. James Barrett,PhD

Chairman of the Board/Director

Gregory S. Patrick

CFO/Chief Accounting Officer/Vice President

Dr. Stefan K.F. Schwabe, M.D., Ph.D.

Chief Medical Officer/Executive VP, Divisional

Jones W. Bryan

Vice President, Divisional

Incorporated

2005

Employees

-

Send Feedback

We appreciate your input!

  • I'm having trouble signing into my Microsoft account

  • I’m having problems with the services stripe (Mail, Facebook, etc.)

  • There is an issue with my weather information

  • I see an error in the content

  • Other

Please give an overall site rating: